Literature DB >> 863190

Stimulation of gastric inhibitory polypeptide in normal and duodenal ulcer patients.

S Cataland, T M O'Dorisio, R Brooks, H S Mekhjian.   

Abstract

To investigate the role of gastric inhibitory polypeptide (GIP), a potent inhibitor of gastric acid secretion, in the hypersecretion associated with duodenal ulcer, we compared the serum GIP concentrations in 11 healthy subjects and 16 duodenal ulcer patients after the stimulation of GIP release by a mixed meal. Fasting and postprandial serum gastrin and GIP concentrations were measured by radioimmunoassay at frequent intervals after the ingestion of a test meal. The duodenal ulcer patients showed an augmented and significantly greater release of GIP as well as of gastrin compared to normal subjects. These results indicate that a defective GIP release cannot account for the gastric hypersecretion seen in patients with duodenal ulcer. The mechanism of the increased GIP response in patients with duodenal ulcer is not clear from these studies.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 863190

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  5 in total

Review 1.  The incretin concept today.

Authors:  W Creutzfeldt
Journal:  Diabetologia       Date:  1979-02       Impact factor: 10.122

2.  Do beta adrenergic agents directly stimulate gastrin secretion?

Authors:  T Kondo; D F Magee
Journal:  Experientia       Date:  1978-05-15

3.  The response of gastric inhibitory polypeptide (GIP) and insulin to glucose in duodenal ulcer patients.

Authors:  K B Lauritsen; A J Moody
Journal:  Diabetologia       Date:  1978-03       Impact factor: 10.122

Review 4.  Clinical aspects of GIP secretion.

Authors:  B Beck; C Villaume; G Debry
Journal:  Acta Diabetol Lat       Date:  1982 Jan-Mar

5.  Endocrinology of duodenal ulcer.

Authors:  W Creutzfeldt; R Arnold
Journal:  World J Surg       Date:  1979-09-20       Impact factor: 3.352

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.